Stay updated on APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial
Sign up to get notified when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.

Latest updates to the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision label in the page footer updated from v3.5.0 to v3.5.2. No visible changes to content or functionality.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedVersion updated from v3.4.3 to v3.5.0, with no visible changes to study details or page interactions.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page adds a new release note: Revision: v3.4.2. The administrative notice about government funding and operating status has been removed, along with a previous release note Revision: v3.4.1.SummaryDifference0.4%

- Check82 days agoChange DetectedA site-wide notice about a lapse in government funding was added, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check89 days agoChange DetectedUI updates include a glossary display option and updated policy/QC labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) with older labels removed. These changes do not affect the study details, eligibility criteria, or results.SummaryDifference0.2%

Stay in the know with updates to APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.